The Division of Oncology is dedicated to developing multidisciplinary and lifesaving treatments for people worldwide who are affected by cancer. At the forefront of ground breaking treatments for cancer, our faculty is involved in more than 100 clinical trials to develop diagnostic and therapeutic approaches to various types of cancer.
‘Cascade’ testing identifies relatives at risk
An online effort coupled with lower costs significantly increased the proportion of cancer patients’ relatives who chose to undergo genetic testing for cancer-associated mutations in Stanford study.
Test predicts lymphoma therapy success
Changes in circulating tumor DNA levels quickly predict how patients with diffuse large B cell lymphoma are responding to therapy, according to a Stanford-led study. Currently, patients wait months for the results.
Common skin cancer linked to other cancers
Frequent skin cancers due to mutations in genes responsible for repairing DNA are linked to a threefold risk of unrelated cancers, according to a Stanford study. The finding could help identify people for more vigilant screening.
How a magnetized wire attracts tumor cells
Scientists at Stanford used the wire to capture free-floating tumor cells in the blood, a technique that soon could be used in humans to yield an earlier cancer diagnosis.
D-limonene could offset dry mouth in cancer patients
A Stanford collaboration between clinical and basic science researchers has led to the identification of a compound that could improve the quality of life for head and neck cancer patients.
Conferences and Workshops
Stanford Review of the 60th Annual American Society of Hematology Meeting 2019
Ritz-Carlton Hotel, Half Moon Bay, CA
New courses are added regularly— please check back often
Non-Stanford CME Courses of Interest
17th Multidisciplinary Management of Cancers: A Case-Based Approach
Join the Mailing List
New activities are added regularly. Join our mailing list to receive notifications about activities of interest to you.